 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Research > Pharsight Corporation
 |
Pharsight Corporation |
 |
 |
 |
PROFILE |
 |
Pharsight just might be the oracle of drug development. The company's products and services help biotech and pharmaceutical firms build and shape their drug pipelines and decrease time and money spent on development. Using computer simulation, statistics, and data analysis along with pharmacology, disease and drug modeling, genetics, and databases of biologic information, Pharsight helps clients determine drug-development targets, quickly develop new drugs, and weed out "no-go" candidates. Its customers include several of the leading pharmaceutical companies; Johnson & Johnson and Pfizer each account for about one-fifth of sales. Pharsight investors include Alloy Ventures and The Sprout Group.
COMPETITION |
 |
Agilent Technologies, Inc. (A)
Applied Biosystems Group (ABI)
Molecular Devices Corporation (MDCC)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: March
2001 Sales (mil.): 11.90
1-Yr. Sales Growth: 33.7%
Employees: 143
Revenue per employee: $83,216.78
KEY PEOPLE |
 |
Arthur H. Reidel
CEO
Robin A. Kehoe
CFO
CONTACT INFO |
 |
800 W. El Camino Real, Ste. 200
Mountain View, CA 94040
US
Phone: 650-314-3800
Fax: 650-314-3810
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |